TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 105.18%2.42M | ---- | -17,175.82%-46.62M | ---- | 101.19%273K | ---- | -228,680.00%-22.88M | ---- | 99.99%-10K |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -72.28%-174K | ---- | -225.81%-101K | ---- | 53.03%-31K | ---- | -53.49%-66K | ---- | -2,050.00%-43K |
Impairment and provisions: | ---- | --81K | ---- | ---- | ---- | -99.77%29K | ---- | 37,336.36%12.35M | ---- | 102.27%33K |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | 174.36%29K | ---- | -165.00%-39K | ---- | 3,100.00%60K |
-Impairment of trade receivables (reversal) | ---- | --81K | ---- | ---- | ---- | ---- | ---- | 774.07%182K | ---- | 83.54%-27K |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --12.21M | ---- | ---- |
Revaluation surplus: | ---- | -104.35%-2M | ---- | --46M | ---- | ---- | ---- | 90.40%-2M | ---- | -94.58%-20.83M |
-Fair value of investment properties (increase) | ---- | -104.35%-2M | ---- | --46M | ---- | ---- | ---- | 90.38%-2M | ---- | -92.59%-20.8M |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -134.04%-32K |
Asset sale loss (gain): | ---- | -1,166.67%-320K | ---- | --30K | ---- | ---- | ---- | ---- | ---- | -3,004.68%-8.63M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---20K | ---- | ---- | ---- | ---- | ---- | ---9.11M |
-Loss (gain) on sale of property, machinery and equipment | ---- | -740.00%-320K | ---- | --50K | ---- | ---- | ---- | ---- | ---- | 75.18%-69K |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --550K |
Depreciation and amortization: | ---- | -1.85%1.49M | ---- | -17.19%1.51M | ---- | -28.01%1.83M | ---- | -34.50%2.54M | ---- | 90.32%3.88M |
-Depreciation | ---- | ---- | ---- | ---- | ---- | -28.01%1.83M | ---- | -34.50%2.54M | ---- | 90.32%3.88M |
Financial expense | ---- | 70.77%8.29M | ---- | 41.60%4.85M | ---- | -28.79%3.43M | ---- | -40.60%4.81M | ---- | 36.36%8.1M |
Special items | ---- | ---- | ---- | ---- | ---- | -1,391.43%-522K | ---- | ---35K | ---- | ---- |
Operating profit before the change of operating capital | ---- | 72.18%9.78M | ---- | 13.49%5.68M | ---- | 194.90%5M | ---- | 69.88%-5.27M | ---- | 54.07%-17.5M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -5,633.33%-498K | ---- | 105.70%9K | ---- | -262.89%-158K | ---- | 249.23%97K | ---- | -3.17%-65K |
Accounts receivable (increase)decrease | ---- | -5,766.07%-174.86M | ---- | 165.55%3.09M | ---- | -2,230.69%-4.71M | ---- | 55.21%-202K | ---- | -145.11%-451K |
Accounts payable increase (decrease) | ---- | 64,460.96%214.99M | ---- | -48.53%333K | ---- | -91.58%647K | ---- | 27.71%7.68M | ---- | 1,592.56%6.02M |
Cash from business operations | ---- | 442.58%49.41M | ---- | 1,060.13%9.11M | ---- | -65.93%785K | ---- | 119.19%2.3M | ---- | 69.03%-12.01M |
Other taxs | ---- | 68.34%-215K | ---- | -68.91%-679K | ---- | ---402K | ---- | ---- | ---- | ---- |
Special items of business | -1,423.69%-14.86M | ---- | -110.47%-975K | ---- | 560.21%9.31M | ---- | 123.45%1.41M | ---- | 104.27%631K | ---- |
Net cash from operations | -1,423.69%-14.86M | 483.74%49.2M | -110.47%-975K | 2,100.52%8.43M | 560.21%9.31M | -83.38%383K | 123.45%1.41M | 119.19%2.3M | 104.27%631K | 69.03%-12.01M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 1,811.36%1.68M | 72.28%174K | 114.63%88K | 225.81%101K | 720.00%41K | -53.03%31K | -88.37%5K | 53.49%66K | --43K | 2,050.00%43K |
Decrease in deposits (increase) | 5.58%3.67M | 73.16%-441K | 83.34%3.48M | 24.18%-1.64M | 225.55%1.9M | -168.53%-2.17M | -3,497.62%-1.51M | 79.34%-807K | -106.21%-42K | -152.79%-3.91M |
Sale of fixed assets | ---- | 6,300.00%320K | --320K | --5K | ---- | ---- | ---- | ---- | ---- | -67.67%311K |
Purchase of fixed assets | 21.29%-196K | -195.24%-372K | -857.69%-249K | 80.34%-126K | 88.98%-26K | -61.46%-641K | -112.61%-236K | 38.26%-397K | 76.97%-111K | -369.34%-643K |
Sale of subsidiaries | ---- | ---- | ---- | --20K | ---- | ---- | ---- | ---- | ---- | --9.7M |
Acquisition of subsidiaries | ---- | ---77K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --11.03M |
Cash on investment | ---305.2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---9.4M |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---13K | ---- | ---- | ---- | ---- |
Net cash from investment operations | -8,349.71%-300.04M | 75.90%-396K | 90.22%3.64M | 41.11%-1.64M | 209.76%1.91M | -145.17%-2.79M | -1,483.64%-1.74M | -115.95%-1.14M | -101.01%-110K | 188.35%7.13M |
Net cash before financing | -11,929.38%-314.9M | 619.26%48.8M | -76.28%2.66M | 381.89%6.79M | 3,479.82%11.22M | -306.43%-2.41M | -163.72%-332K | 123.93%1.17M | 113.41%521K | 89.60%-4.87M |
Cash flow from financing activities | ||||||||||
New borrowing | -736.43%-25.46M | -41.39%9M | 60.00%4M | 53.57%15.36M | -50.00%2.5M | -78.26%10M | -88.37%5M | 136.03%46M | 464.16%43M | --19.49M |
Refund | ---16M | ---- | ---- | ---18M | ---6.08M | ---- | ---- | -432.98%-40M | -1,966.12%-40M | ---7.51M |
Issuing shares | --353.36M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Interest paid - financing | -15.49%-4.44M | -70.77%-8.29M | -117.52%-3.85M | -41.60%-4.85M | -1.67%-1.77M | 27.68%-3.43M | 39.31%-1.74M | 40.66%-4.74M | 25.59%-2.87M | -38.22%-7.99M |
Absorb investment income | ---- | --218K | --245K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from financing operations | 178,812.27%291.3M | 98.17%-160K | 97.26%-163K | -258.08%-8.72M | -317.50%-5.95M | 4,217.16%5.52M | 487.68%2.74M | -111.35%-134K | -244.97%-706K | 120.44%1.18M |
Effect of rate | -314.36%-403K | 46.77%-544K | 141.59%188K | -785.91%-1.02M | -223.84%-452K | 1,590.00%149K | --365K | -123.81%-10K | ---- | -92.38%42K |
Net Cash | -1,044.26%-23.6M | 2,612.50%48.64M | -52.56%2.5M | -162.25%-1.94M | 119.04%5.27M | 201.36%3.11M | 1,400.00%2.41M | 127.96%1.03M | 94.55%-185K | 92.98%-3.69M |
Begining period cash | 1,585.82%51.13M | -49.37%3.03M | -49.37%3.03M | 119.29%5.99M | 119.29%5.99M | 59.77%2.73M | 59.77%2.73M | -68.09%1.71M | -68.09%1.71M | -90.67%5.36M |
Cash at the end | 374.32%27.13M | 1,585.82%51.13M | -47.07%5.72M | -49.37%3.03M | 96.42%10.81M | 119.29%5.99M | 260.79%5.5M | 59.77%2.73M | -21.59%1.53M | -68.09%1.71M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Auditor | -- | Zhi Bao Xin Qin Certified Public Accountants Limited | -- | Fan Chen Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.